IndraLab

Statements

UCHL3 inhibitors inhibits UCHL3. 1 / 1

| 1

reach

"From the cancer point of view, UCHL3 is an attractive " druggable " target and previous efforts focused on developing UCHL3 inhibitors that specifically target UCHL3 in plasmodium falciparum parasite, offering promising selectivity due to structural differences compared to human UCHL3."

29898404

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

UCHL3 inhibitors inhibits UCHL3. 1 / 1

INDRA sources:

Databases

Reading